1. Home
  2. NFGC vs ABCL Comparison

NFGC vs ABCL Comparison

Compare NFGC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Found Gold Corp

NFGC

New Found Gold Corp

HOLD

Current Price

$2.18

Market Cap

928.8M

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.11

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NFGC
ABCL
Founded
2016
2012
Country
Canada
Canada
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
928.8M
1.1B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
NFGC
ABCL
Price
$2.18
$5.11
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$8.40
AVG Volume (30 Days)
1.7M
6.2M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
$3,542.00
N/A
Revenue Next Year
$118.57
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
160.56
52 Week Low
$1.19
$1.94
52 Week High
$3.59
$6.52

Technical Indicators

Market Signals
Indicator
NFGC
ABCL
Relative Strength Index (RSI) 54.37 75.89
Support Level $1.85 $3.89
Resistance Level $2.34 $6.52
Average True Range (ATR) 0.12 0.35
MACD 0.02 0.09
Stochastic Oscillator 67.78 93.92

Price Performance

Historical Comparison
NFGC
ABCL

About NFGC New Found Gold Corp

New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: